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ABSTRACT 
In this study, six different types of cellulose acetate butyrate (CAB) were used to 
rnicroencapsulate ascorbyl palmitate. Their molecular weight ranged from 53,937 to 
264,362. They have varying acetyl, butyryl and hydroxyl contents. By using non-
solvent addition microencapsulation method, ascorbyl palmitate microcapsules were 
prepared with each fraction and their physical chemical properties including yield, 
mean particle size, size distribution, degree of aggregation, drug loading and release 
characteristics were evaluated. 
The relationship between the formulation variable responses including rnicrocapsule 
yield, rnicrocapsule size, size distribution, drug loading and degree of aggregation and 
the polymer molecular weight, viscosity of the polymer solution and polydispersity of 
the polymer were evaluated by Stepwise Regression Analysis. The effects of molecular 
weight of cellulose acetate butyrate on the formulation variables but drug loading were 
significant. The mean particle size and size distribution of microcapsules increased 
with increasing molecular weight. Solution viscosity and polydispersity of the polymer 
also affected the mean particle size. The microcapsules made with lower molecular 
weight polymer caused more aggregation. Drug loading was affected by the solution 
viscosity and polydispersity. Stepwise Regression Analysis also indicated that 
viscosity and polydispersity of the polymer were also influenced by polymer molecular 
weight. Higher molecular weight of the polymer results in the higher viscosity and 
larger polydispersity. 
II 
( The burst release was influenced by both the solution viscosity and polydispersity of 
the cellulose acetate butyrate. Higher viscosity of the polymer solution and smaller 
degree of polydispersity resulted in the smallest burst effect. The steady state release 
profiles fitted equally well to both HIGUCHI and Zero Order Equations. However, 
there is no significant difference between the steady state release rates of the six 
polymers. 
Lower viscosity of the polymer solution resulted in larger amount of release in one and 
eight hours. Polydispersity also affected the total amount release in one hour. The total 
release in one hour increased with larger degree of polydispersity. 
lll 
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PREFACE 
Microencapsulation is one of the frequently employed controlled release methods in 
pharmaceutical and cosmetic technologies. Besides release control it is also used to 
protect the microencapsulated drug substances from degradation. The release of 
compounds from these polymer systems is not always predictable, in part due to a lack 
of understanding on the effects of the properties of the polymer on the final product. 
The performance of microcapsules are affected by the properties of polymer, such as 
molecular weight, viscosity of the polymer solution and polydispersity of the polymer. 
The effect of polymer molecular weight on the microencapsulation variables was 
studied and published by Jalil and Nixon58. By using poly(L-lactic acid) and 
phenobarbitone, they demonstrated that the molecular weight differences of poly(L-
lactic acid) affected the particle size, degree of aggregation and release rate of the 
microencapsulated phenobarbitone. The larger molecular weight fraction increased the 
mean particle size, decreased release rate and aggregation. However, in their study, the 
possible effects of the corresponding solution viscosity and polydispersity of the 
polymer were not identified. 
In this study, by using different molecular weight fractions of cellulose acetate butyrate 
with varying viscosity and polydispersity, the effects of molecular weight, solution 
viscosity and polydispersity of the polymer on the surface characteristics, yield, mean 
v 
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particle size, particle size distribution, drug loading and degree of aggregation of 
ascorbyl palmitate microcapsules were determined in addition to release characteristics 
of ascorbyl palmitate. 
VI 
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( I. INTRODUCTION 
1.1 PURPOSES OF MICROENCAPSULATION 
Microencapsulation is one of the frequently employed controlled release methods in 
pharmaceutical and cosmetic technologies. It can be conceived as a technique of 
trapping active materials in rather stable and protective coatings. The size of 
microcapsules initially ranges from 5µm to hundred microns and has been getting 
smaller as the new techniques and new products have been developed. The diameter 
of nanoparticles are much smaller and of 10 to 1000 nm. Microparticles of different 
dimensions can be applied to various applications. The micropartcles with the size 
less than 5um can be used for intravenous therapy and prolong the release of a drug. 
Numerous studies have been carried out to encapsulate various materials for the 
purposes of targeted delivery, reducing irritating capacity of drugs 1, controlled release 
of drugs, improving drug stability and availability2, isolating drug from tissues, 
masking unpleasant taste or aidi~g in storage or handling3.4. Some examples are given 
in Table I. Besides solid microcapsules, non-solid form microcapsules are also 
available such as liposomes, which are very popular in both pharmaceutical and 
cosmetic fields. 
Microcapsule morphology depends on the process parameters and manufacturing 
methods3·37. Those morphology can be basically categorized to six different types as 
shown in Figure 1. 
N 
Table I : Examples of Microencapsulated Drugs 
Purpose of Microencapsulation Coating Agent 
Improved Stability Liposomes 
\ 
\ 
' 
Drug/Active Substance 
Dexamethasone Sodium 
Phosphate 
Reduced Volatility Acacia Aromatic Oils 
Irritation/toxicity reduction Cellulose Acetate butyrate Carbamazepine 
Cellulose Acetate Propionate Theophylline 
Chitin 6-Mercaptopurine 
Chitosan 5-Fluorouracil 
Ethylcellulose Theophylline 
Eudragit Indomethacin 
Poly(lactic/glycolic) acid Bupivacaine 
" Lidocaine 
Reference 
2 
5 
6 
7 
8,9 
10 
11 
12 
13 
13 
\ 
.-, 
\ 
Table I (continuation) 
Purpose of Microencapsulation Coating Agent Drug/ Active Substance Reference 
Sustained release Poly(lactic/glycolic) acid Etidicaine 13 
Cellulose Acetate Verapamil Hydrochloride 14 
Cellulose Acetate Propionate Verapamil Hydrochloride 14 
Cellulose Acetate Butyrate Diltiazem Pectate 15 
" Ibuprofen 16 (.;.) 
Cellulose Acetate 2,4-dinitrophenyl-hydrazine 17 
Trimellitate 
" Tartrazine 18, 19 
EthyleneNinylacetate Dimethyldidecylamonium 20 
Copolymer Chloride 
Cellulose Acetate Ketoprofen 21 
Butyrate/Polystyrene 
Ethycellulose Allopurinol 22 
Eudragit Acetylsalicylic acid 23 
Table I (continuation) 
Purpose of Microencapsulation 
Sustained Release 
Improved bioavailablity 
.j::>. 
Improved Stability 
\ 
\ 
\ 
Coating Agent 
Polylactic acid 
Poly(lactic/glycolic) acid 
" 
Alginate 
Ethylcellulose 
poly( carboxyphenox yvaleric 
acid) and 
poly( carboxyphenoxyhexane) 
Polylactic acid 
Poly(lactic/glycolic) acid 
" 
" 
------... 
Drug/ Active Substance Reference 
Quinidine 24 
AZT 25 
Proteins 26 
Trypsin 27 
5-Fluorouracil 28 
p-Nitrophenol, 29 
Lysozyme 
Thymopentin 30 
Bovine serum albumin 31 
Rismorelin porcine 32 
Cholecystokinin 33 
Derivative Peptide 
Table I (continuation) 
Purpose of Microencapsulation 
Taste masking 
Targeted delivery 
Easy handling 
VI 
·:( 
' i
\ 
Coating Agent Drug/ Active Substance 
Cellulose Acetate Propionate Theophylline 
Eudragit Chloroquine Diphosphate 
Poly(lactic/glycolic) acid Ciprofloxacin 
Gelatin/Gum Arabic Eprazinone 
Reference 
7 
34 
35 
36 
Homogeneous 
or gel type 
microsphere 
Monolithic 
(matrix type) 
microcapsule 
Resetvior 
(mononuclear) 
microcapsule 
••• Resevoir 
(polynuclear) 
microcapsule 
Double core 
microcapsule 
Double wall 
microcapsule 
Figure 1 : Schematic Presentation of Different 
Types of Microspheres and 
Microcapsules. (From Ref. 3) 
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1.2 POLYMERS USED FOR MICROENCAPSULATION 
Various polymers have been used for microencapsulation. Some of them are listed on 
Table II. These can be used alone or combined with other polymers to form the coating. 
Some commonly used polymers include alginates27.4°, cellulose acetate 14, cellulose 
acetate butyrate6·14· 16.4 144, cellulose acetate phthalate38•45 , cellulose acetate 
propionate7' 14, cellulose acetate trimellitate17-19, chitin8•9, chitosan 10, ethyl 
cellulose 11 '22•28.46-52, Eudragits 12•23•34•53 , poly lactic acid 13·24•30•31 •54·59, polymethyl 
methacrylate 47 , polystyrene 47, polyvinyl chloride 47 , gelatin-acacia60, 
ethylene/vinylacetate copolymer20, combination of cellulose acetate butyrate and 
polystyrene21 , poly(carboxyphenoxyvaleric acid) and poly(carboxyphenoxyhexane)29 , 
poly(lactic/glycolic acid) copolymer13•25•26•30-33•35•61 . The list of the polymers and the 
microencapsulation methods are presented in Table II. 
1.3 METHODS WIDELY USED FOR POLYMER BASED 
MICROENCAPSULATION 
1.3.1 Coacervation Technique 
"Coacervation" was first introduced by the Dutch scientists Bungenberg de Jong and 
Kruyt in 192962• The term is meant to describe macromolecular phase separation 
process caused by partial desolvation of fully solvated macromolecules. For a 
successful microencapsulation carried out by the coacervation method, the core material 
and the polymer must be insoluble or poorly soluble in the coacervation medium. There 
7 
\ 
\ 
Table II : Polymers Used for Microencapsulation 
Polymer Degradibility Drug Encapsulated Microencapsulation Method Reference 
in the Body 
Acacia yes Aromatic Oils Spray Drying 5 
Alginate yes Trypsin Coacervation Method 27 
Cellulose Acetate no Verapamil Hydrochloride Solvent Evaporation Method 14 
Cellulose Acetate Butyrate no Carbamazepi ne Solvent Evaporation Method 6 
" " Verapamil Hydrochloride Solvent Evaporation Method 14 
" " Diltiazem Pectate Solvent Evaporation Method 15 
00 
" " Ibuprofen Solvent Evaporation Method 16 
" " Propranolol HCl Solvent Evaporation Method 41 
Paracetamol a)Solvent Evaporation Method 42 
" " " b)Emulsion Non-Solvent Addition 42 
Method 
" " Propranolol Emulsion Non-Solvent Addition 43 
Method 
" " Phenylpropanolamine HCl Solvent Evaporation Method 44 
Table II (continuation) 
Polymer Degradibility 
in the Body 
Cellulose Acetate Phthalate no 
\0 
Cellulose Acetate Propionate no 
II II 
Cellulose Acetate no 
Trimellitate 
II II 
Cellulose Acetate no 
Butyrate/Polystyrene 
Chitin yes 
' \ 
' 
Drug Encapsulated 
Potassium Chloride, 
Sucrose, Caffeine, 
Tetracycline HCl, 
Barium Sulfate, Cornstarch, 
Sulfasalazine, 
Hydrochlorothiazide 
Theophylline 
Verapamil Hydrochloride 
2,4-dinitrophenyl-hydrazine 
Tartrazine 
Ketoprofen 
6-Mercaptopurine 
--
Microencapsulation Method Reference 
Emulsion Non-Solvent Addition 45 
Method 
Solvent Evaporation Method 7 
Solvent Evaporation Method 14 
Emulsion Non-Solvent Addition 17 
Method 
Emulsion Non-Solvent Addition 18, 19 
Method 
Complex Emulsion Method 21 
Non-Solvent Addition Method 8,9 
Table II (continuation) 
Polymer Degradibility 
in the Body 
Chitosan yes 
Ethylcellulose no 
II 
II 
0 
II 
II II 
II II 
II II 
II II 
II II 
\ 
\ 
\ 
Drug Encapsulated 
5-Fluorouracil 
Theophylline 
Ibuprofen 
Allopurinol 
5-Fluorouracil 
Sodium Diclofenac 
Caffeine, 
Salicylic acid 
Acetylsalicylic acid 
II 
Phenylpropanolamine 
Hydrochloride 
Microencapsulation Method Reference 
Emulsion Non-Solvent Addition 10 
Method 
Non-Solvent Addition Coacervation I I 
Method 
Solvent Evaporation Method 16 
Solvent Evaporation Method 22 
Solvent Evaporation Method 28 
Solvent Evaporation Method 46 
Fluidized Bed Coating 48 
Non-Solvent Addition Coacerv ati on 49 
Method 
Emulsion Non-Solvent Addition 51 
Method 
Emulsion Non-Solvent Addition 52 
Method 
Table II (continuation) 
Polymer 
Eudragit 
II 
II 
II 
Gelatin/ Acacia 
po I y( carbox yphenox yvaleric 
acid) and 
poly( carboxyphenoxyhexane 
Polystyrene 
Polyvinyl Chloride 
Polymethyl Methacrylate 
\ 
\ 
\ 
Degradibility Drug Encapsulated 
in the Body 
yes 
II 
II 
II 
yes 
yes 
no 
no 
no 
Indomethacin 
Acetylsalicylic 
Chloroquine Diphosphate 
Salbutamol 
Indomethacin 
p-Nitrophenol, 
Lysozyme 
Gelatin 
Gelatin 
Gelatin 
Microencapsulation Method 
Solvent Evaporation Method 
Non-Solvent Addition Coacervation 
Method 
Non-Solvent Addition Coacervation 
Method 
Air Suspension Coating 
Non-Solvent Addition Coacervation 
Method 
Solvent Evaporation Method 
Emulsion Non-Solvent Addition 
Method 
Solvent Evaporation Method 
Solvent Evaporation Method 
Solvent Evaporation Method 
,,.--.. 
Reference 
12 
23 
34 
53 
60 
29 
47 
47 
47 
\ 
\ 
Table II (continuation) 
Polymer Degradibility Drug Encapsulated Microencapsulation Method Reference 
in the Body 
Polylactic acid yes Quinidine Solvent Evaporation Method 24 
II II Thymopentin Solvent Evaporation Method 30 
II Indomethacin, Piroxicam Centrifugation Method 54 
II II Phenobarbitone Solvent Evaporation Method 55-58 
Poly(lactic/glycolic) acid yes Bupivacaine, Solvent Evaporation Method 13 
Etidicaine, 
-N 
Lidocaine, 
Mepivacaine 
II II AZT Solvent Evaporation Method 25 
II II Proteins Solvent Evaporation Method 26 
II II Bovine serum albumin Solvent Evaporation Method 31 
II II Rismorelin porcine Solvent Evaporation Method 32 
II Cholecystokinin Derivative Solvent Evaporation Method 33 
Peptide 
Table II (continuation) 
Polymer Degradibility 
in the Body 
Poly(lactic/glycolic) acid yes 
II II 
EthyleneNinylacetate no 
Copolymer 
-
--
\>) 
\ 
\ 
', 
Drug Encapsulated 
Ciprofloxacin 
Protein 
Dimethyldidecylamonium 
Chloride 
Microencapsulation Method Reference 
Solvent Evaporation Method 35 
Evaporation-Extraction Method 
Solvent Evaporation Method 61 
Solvent Evaporation Method 20 
/ 
,,_ ..... 
are two types : simple and complex coacervation. Simple coacervation involves using 
only one polymer solution, then remove the solvent by adding a non-solvent which have 
a greater affinity for the solvent11 ·49· 63-68. Then the desolvated polymers will precipitate 
out with surrounding molecules to form the microcapsules. 
Wu et al. 11 used ethylcellulose to microencapsulate theophylline by simple 
coacervation, non-solvent addition, method. Ethylcellulose was dissolved in a solvent 
(dichloromethane, acetone and ethylacetate), then theophylline was dispersed the 
polymer solution with stirring. Coacervation was induced by adding a non-solvent 
(cyclohexane and n-hexane) dropwise to the suspension. Microcapsules were then 
collected by filtration. 
Besides non-solvent addition, heating can also be used to induce phase separation by 
reducing the solubility of the polymer solution. Paradissis and Parrott65 used gelatin to 
microencapsulate several drugs. The drug was dispersed in mineral oil in the aqueous 
gelatin solution. The phase separation was then achieved by adding isopropanol and 
reducing the temperature. 
Complex coacervation is similar to simple coacervation except that complex 
coacervation mainly involves the neutralization of the charges on the colloid49· 68-71 . The 
charge neutralization is caused by adding two opposite charged polymers together; 
which results in the reduction of net charge and the loss of solvation of the polymers. 
This causes the precipitation of the polymers forming a complex coacervate of the 
14 
I colloids and further forming microcapsules. The negatively charged acacia is the most 
widely used polymer for positively charged gelatin for complex coacervation69-72. 
Temperature adjustment can also be used to coacervate the polymer solution if the 
solubility of the polymer changes with the variation in temperature. Jizomoto72 
prepared gelatin-acacia microcapsules containing paraffin oil. The paraffin oil was 
stirred into the gelatin-acacia solution at 50 - 60°C. Polyethyleneglycol or 
polyethyleneoxide was added as a desolvating agents, then the mixture was cooled 
down to form the microcapsules. 
1.3.2 Solvent Evaporation Method 
Solvent evaporation method is a very popular microencapsulation technique used in 
many studies6·7·14•16·22.41•42•44.46.47•55·56•58•68•73 . The origin of the solvent evaporation 
microencapsulation method can be traced to the late 1960s. An early work has done by 
Vranken and Claeys74 to microencapsulate dyes with polystyrene by using solvent 
evaporation method. 
Two basic steps to produce microcapsules by solvent evaporation method are the 
emulsion formation and solvent removal. The polymer used is first dissolved in a 
solvent and then the core material is dispersed or dissolved in the polymer solution. The 
mixture acts as the dispersed phase and is further emulsified into an immiscible liquid 
which may contain an stabilizer and form an emulsion. The evaporation of the solvent 
is then achieved with continuous stirring. Microcapsules thus form. 
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( As the solvent evaporates from the emulsion, the viscosity of the dispersed phase keeps 
increasing that will destabilize the whole system. The highly viscous droplets tend to 
aggregate during the solvent removal. Therefore a droplet stabilizer usually is needed to 
form a thin layer around the droplets which results in reducing the extent of collision 
and coalescence between the droplets. The effect of the stabilizer will be discussed in 
1.4.1.2.1. 
1.3.3 Pan Coating 
The process of pan coating was first described by Blythe75 . Pan coating for 
microencapsulation is a highly skilled operation and rather time-consuming. A typical 
method of coating a drug by pan coating involves roughening the pan first before use by 
( coating with an adhesive solution composed of 10% polyvinylpyrrolidone in 
isopropanol. Sprinkle with talc when the pan becomes tacky and then pat with a damp 
cloth to produce a stippled surface upon drying. The core drug should be screened first 
to remove dust in order to form more regular microcapsules. Then the coating solution 
is sprayed over the drug which is already in the pan. Coating is continued until the 
needed wall thickness is obtained. Talc is added intermittently to reduce particle 
. 4 
aggregation . Brophy and Deasy76 used ethylcellulose and 
hydroxypropylmethylcellulose to pan-coat methylene blue-containing cores. Harris 77 
coated potassium chloride with cellulose acetate phthalate by the same method. 
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1.3.4 Air Suspension Coating 
Air suspension coating is a good alternative to pan coating becuase it can provide better 
and more uniform coating on small core materials irrespective of the size and shape of 
the core. The process is easier to operate and faster than the pan coating. Air 
suspension coating was first developed by Wurster, therefore the process is also called 
Wurster coating78• 79 . 
The typical Wurster coating equipment is shown in Figure 2. The solid cores are placed 
in the coating chamber and fluidized by a high velocity airstream. As a result, the core 
drugs pass through the coating spray which is from the atomizer nozzle, and the air can 
rapidly dries the particles as it rises into the coating partition. Then the cores goes up to 
the expansion chamber where is no airstream to support the particles, therefore the 
particles will drop down through the annular space where they can be further dried 
before reentering the coating partition · and being further coated again. By this method, 
the thickness of the wall can be controlled. 
1.3.5 Spray Drying 
Spray drying is a technique which is used mainly for a wide range of drugs and 
flavors35•80-82. The wall of the microcapsules produced by spray drying tends to be more 
porous which is suitable to taste masking and other purpose but not controlled release. 
The instrument and the running cost and are high comparing to other 
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microencapsulation techniques. A diagram of a typical spray dryer is shown in Figure 3. 
Spray drying technique involves dispersing the core drug into the polymer-containing 
solution. The mixture is then atomized and the solvent is spray dried in a spray dryer 
which results in the encapsulation of the drug. Granatek et al.80 dispersed dicloxacillin 
sodium particles in a methylene chloride solution containing ethylcellulose and 
spermaceti. The mixture was then spray dried to form microcapsules. Many aromatic 
oils used as flavors were emulsified in a acacia solution and then spray dried to form 
free-flowing powers with reduced volatility5. 
1.3.6 Emulsion Non-Solvent Addition Method 
Emulsion non-solvent addition method is or; similar to coacervation technique which 
was used in this study. Emulsion non-solvent addition microencapsulation method was 
first developed by Liard et al.52 in 1984. They used ethylcellulose as the wall material 
and aimed to perform the coacervation process by using innocuous or easily removed 
solvents. Three steps were needed to achieve the emulsion non-solvent addition 
microencapsulation. First, the organic phase was formed by dissolving polymer in the 
solvent used in which the core material was either dissolved or suspended. Second, 
emulsification took place by adding a non-miscible oil phase with stirring. The last step 
was the addition of a non-solvent which can harden the wall material and thus the 
microcapsules form. The non-solvent used in emulsion non-solvent addition 
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microencapsulation method should be miscible with the solvent, in which both the 
polymer and drug remain insoluble. The purpose of the addition of a non-solvent is to 
compete with the polymer for the solvent affinity. Due to the weak affinity between the 
polymer and the solvent, polymer would precipitate out and encapsulate the drug. The 
difference in the solubility parameters of the solvent and the non-solvent would affect 
the microcapsules formation rate and release rate11 . The microcapsules formation rate 
and release rate are faster with smaller solubility parameter difference. The flow chart 
of the procedure is shown in Figure 4. 
In the method used by Liard et al.52, ethylcellulose was selected as the wall material, 
acetone as the solvent, hexane as the non-solvent and the mineral oil and petroleum 
ether as the oil phase. 
By using emulsion non-solvent addition technique, the optimal formation of coacervate 
droplets and reproducible properties can be achieved. Besides, this method has the 
advantage of carrying out the process at the room temperature. Following Liard et al's 
study, several studies using cellulose acetate butyrate42.43, cellulose acetate phthalate45, 
cellulose acetate trimellitate 17-19, chitosan 10, ethylcellulose51 •52, and Eudragit23•34 to 
perform microencapsulation with the emulsion non-solvent addition method. Both oil-
in-water and water-in-oil emulsions can be used in this method. The emulsion non-
sol vent addition method provides a wide variety for microencapsulation, no matter 
whether the core material is hydrophilic or hydrophobic, liquid or solid, soluble or 
insoluble in the polymer solvent. 
21 
( 
( 
( 
Flow Chart of Emulsion Non-Solvent Addition Method 
POLYMER 
SOLVENT ~ ! 
POLYMER SOLUTION 
! ~ DRUG 
SOLUTION I DISPERSION 
DISPERSING MEDilJM 
+SURFACTANT 
+DISPERSANT ! 
EMULSION 
! ~ NON-SOLVENT 
HARDENING 
FILTRATION 
MICROCAPSULES 
Figure 4 : Flow Chart of Emulsion Non-Solvent Addition Method 
22 
f 
,- ·"' 
In Sprockel and Prapaitrakul's method42, a model drug, paracetamol, was dispersed in 
acetone which contained 6% cellulose acetate butyrate as the wall material. The drug 
dispersion was then emulsified in mineral oil containing 1 % Span 80. Hexane was used 
as a non-solvent and added to the emulsion. The microcapsules thus formed were 
collected, washed and dried after complete addition of hexane. 
In that paper, the objective was to optimize cellulose acetate butyrate encapsulation of 
paracetamol by choosing the best microencapsulation method. Emulsion non-solvent 
addition method appeared to be the most practicable method while using cellulose 
acetate butyrate as the coating polymer. 
Effects of drug to polymer ratio and particle size on dissolution characteristics were 
studied by Chiao and Price41 by using cellulose acetate butyrate. It was found that 
smaller particles and slower release rate could be obtained at smaller ratio of drug to 
polymer (1/2). The same result was also observed by Bhardwaj et al. 14• Cellulose 
acetate trimellitate was used to investigate the effects of polymer to solvent 
concentration and internal phase volume fraction on the particle size distribution. It was 
found that the lower the polymer to solvent concentration and internal phase volume 
fraction, the smaller the particles became9. Smaller microcapsules could be also 
obtained by increasing stirring rate during the production24• 
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1.4 VARIABLES THAT AFFECT PROPERTIES OF POLYMER BASED 
MICROCAPSULES 
1.4.1 Variables That Affect Particle Size and Particle Size Distribution 
The particles size and distribution are associated with the relative rate of separation and 
coalescence of the dispersed phase droplets. If the emulsion particles are formed faster 
than they coalesce, then smaller microcapsules can be obtained. Those influencing 
factors related to microcapsule size include interfacial tension between the dispersed 
and continuous phases, viscosity of the two phases, volume fraction of the dispersed 
phase and agitation conditions20·25·32•31•47.49. 
1.4.1. l effects of process variables 
1.4.1 .1.1 agitation type and speed 
Higher stirring speed provides stronger turbulence force to form the dispersed droplets 
and increases the separation rate of the droplets. The relationship between the particle 
size and stirring speed has been widely demonstrated20•32• Smaller particles and 
narrower particle size distribution can be obtained by increasing the stirring speed. 
Legrand et al.20 investigated the effect of rotational speed on particle size. Higher 
stirring velocity, 500rpm, produced the microcapsules with the mean size of 150um, 
which was smaller than the mean size of microcapsules produced with 250 and 30Qrpm, 
whose mean particle size were 350um and 300um. In the same study, the yield and drug 
loading were also found affected by the stirring speed. Yield was found a parabolic 
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function of the stirring speed with the highest value obtained at the stirring speed about 
300-320rpm. The optimum drug loading efficiency was found as 60% at the stirring 
speed between 260 and 400 rpm. Drug loading decreased significantly with the stirring 
speed faster than 400 rpm. 
The homogeneity of the turbulence produced also has an effect on particle size 
distribution. The more uniform turbulence can be achieved by using an impeller with 
diameter as large as possible to fit in the processing vessel37 • The variation of sheer 
force throughout the vessel is then minimized, and the smaller particle size and 
narrower distribution can be expected. 
1.4.1.2 effects of formulation variables 
1.4.1.2.1 interfacial tension 
In an emulsion, surfactants are used to reduce the interfacial tension of the two phases. 
The nature of the surfactant and its concentration play an important role in reducing the 
interfacial tension and stabilizing the dispersed droplets against coalescence. Several 
works have been done to study the effect of surfactant type and surfactant concentration 
on the size of microcapsules 16•18•22•32.45•51 . Chen et al.51 used Tween 20, Tween 60 and 
Tween 85 to study the effect of surfactant type on the ethylcellulose microcapsules of 
theophylline. They found that the mean particle size, yield and drug content increased 
with the decrease in the HLB value of the surfactants used. Different surfactants might 
lead to the variation in particle size. Beyger and Naim45 used Span 80 to produce 
cellulose acetate phthalate microcapsules and found that the particle size decreased as 
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the surfactant concentration increased. However, when the concentration of Span 80 
exceeded 1 %, the mean particle size started increasing and degree of aggregation also 
increased. Generally, particle sizes were found to be inversely affected by surfactant 
concentration because the surface energy was reduced more with higher surfactant 
· h. h 1 d · h · · f h rf 161822324551 concentrat10ns w 1c resu te m t e easier creat10n o t e new su aces · · · · · . 
However, the studies concluded that the influence of the surfactant on the particle size 
could be minimized by the high energy input by stirring into the system which provided 
the work needed to create new surf aces. 
1.4.1.2.2 viscosity and volume fraction of the dispersed phase 
A viscous dispersed liquid retards the emulsification rate and forms a relatively coarse 
emulsion with larger droplet size. A high dispersed phase volume fraction increases the 
probability of the collision between the droplets since the density of dispersed droplets 
in the fixed vessel is higher. As a result, the coalescence rate increases and the size of 
microcapsules increases. This may also result in a wider particle size distribution. 
Both the molecular weight22·56·58 and concentration12·19·83·84 of the polymer affect the 
viscosity of the polymer solution. Either increasing polymer concentration or using a 
polymer with higher molecular weight will result in larger microcapsules. Sanghvi and 
Naim 19 had investigated the effects· of the concentration of cellulose acetate trimellitate 
and internal phase volume fractions on the particle size distribution of tartrazine 
microcapsules, they used solvent evaporation method to control the microcapsule 
particle size and regulated the ratio of the polymer to solvent concentration and the 
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( volume fraction . Three polymer concentrations were used, 8, 10 and 12%. It was found 
that the lower the polymer to solvent concentration and internal phase volume fraction , 
the particles became smaller. In an earlier study, the same authors used cellulose acetate 
trimellitate to study the effects of the viscosity of both the dispersed and external phase 
on microcapsule size in an emulsion type of microencapsulation system17• Particle size 
of microcapsules was found to increase in more viscous dispersed phase which were 
obtained by higher concentration of the polymer dissolved. The opposite effect was 
observed for the viscosity of the external phase; an increase in the particle size was 
found when the external phase was changed from light mineral oil to heavy mineral oil. 
1.4.1 .2.3 drug to polymer ratio 
Several studies that appeared in the literature studied the effects of the drug to polymer 
ratio on the microcapsules size12·34.4J.s6,ss.ss. Smaller ratio of drug to polymer was found 
to produce smaller microcapsules and faster release rate. For example, Bhardwaj et al. 14 
used cellulose esters to evaluate the effect of drug loading on the particle size and size 
distribution. The mean particle diameter obviously increased when the drug loading 
increased from 33.3% to 50%, but the particle size distribution did not vary much. 
Chiao and Price41 observed the same results when drug to polymer ratio of Propranolol 
HCl microcapsules increased from 1/2 to 1/1. The smallest mean particle size was 
obtained with the lowest drug to polymer ratio(l/2). The phenomenon can be attributed 
to the relative increase in the total solid content of the internal phase which results i.n an 
increase in viscosity of the dispersed phase which results in the increased particle size. 
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1.4.2 Variables that Affect Release Rate 
In diffusion-based release, release of the core drug through a polymer coating involves 
three possible steps; the first is the penetration of the dissolution medium into the core 
which is followed by the dissolution of the drug and the removal of the solute to the 
bulk solution via diffusion. The rate-determining step in this type of release would be 
the diffusion rate provided that the core drug is soluble in the dissolution medium. 
However, if the core drug is poorly soluble in the medium, the dissolution of the drug 
becomes important as the rate-determining step. Therefore, the release rates of the 
microcapsulated drugs from the polymer walls is chiefly affected by the variation of the 
permeability of the polymer, the solubility of the encapsulated drug, the molecular 
weight of the polymer, the ratio of drug to polymer wall and the size of microcapsules. 
1.4.2.1 permeability of the polymer 
The high pore volume or the surface defects of the microcapsules and the nature of the 
coating polymer would influence the release rate by facilitating the dissolution medium 
through the coating and increasing the release from the polymer, since the polymer is 
more permeable to the dissolution medium. Several studies had been done to determine 
the two ways of release through the porous polymer86-88• Release of the drug through 
the diffusion process and through the pores formed in the membrane are both important 
factors for the release of the drug. The porosity of the microcapsules affects the release 
even more when the encapsulated drug is poorly soluble in the dissolution medium. 
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1.4.2.2 molecular weight of polymer and drug loading 
Release from microcapsules were also influenced by polymer molecular weight and 
drug loading. Polymers with higher molecular weight tend to lower the release of drugs 
more than lower molecular weight polymers7'22·54·57 . Lower drug loading microcapsules 
had slower release because the ratio of the amount of drug to polymer determines the 
thickness of the microcapsule wall or polymer path. Thicker walls that the drug 
molecules should overcome while diffusing to the dissolution medium as matrix which 
is formed with lower drug to polymer ratios, provides a longer path to penetrate 
through, therefore slower release rates are obtained7• 14• 57 . 
Jalil and Nixon57 used poly(DL-lactic acid) and phenobarbitone to demonstrate that the 
molecular weight differences of poly(DL-lactic acid) affected the release rate of the 
microencapsulated phenobarbitone. Poly(DL-lactic acid) of three different molecular 
weight were used (5200, 13300 and 20500). The release rate from the microcapsules 
prepared with the poly(DL-lactic acid) with the highest molecular weight provided the 
slowest release rate. In the same study, drug to polymer ratio was also demonstrated 
having an effect on release rate. The quantity of the drug released from the 
microcapsules decreased when the drug to polymer ratio decreased. 
Another study carried out by Shukla and Price7 using cellulose acetate propionate with 
three different molecular weights to investigate the effect of polymer molecular weight 
and different drug loading (40%, 50% and 60%) on the release characteristics. They 
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( demonstrated that the higher molecular weight polymer and higher drug loading greatly 
prolong the release half-lives. 
1.4.2.3 particle size of microcapsules 
Particle size of rnicrocapsules plays an important role in the release rates. Release rate 
increases as the surface area of the rnicrocapsules increases. Therefore with the same 
concentration of encapsulated drug used in the dissolution medium, decreased particle 
size microcapsules provide faster release rates.7•41 '44 Arabi et al. 22 studied the effect of 
the polymer molecular weight and rnicrocapsules size on the release of allopurinol by 
using ethyl cellulose as the wall material. Smaller size ( 1 OOum) microcapsules showed 
slower release compared to the rnicrocapsules with the size of 250um. 
1.4.2.4 solvent and non-solvent pairs 
In the non-solvent addition microencapsulation method, the choice of solvent and non-
solvent could affect the release of the core material. The miscibility of the solvent and 
non-solvent is higher with smaller solubility parameter differences. The larger 
differences of the solubility parameters therefore results in slower formation of the 
microcapsule wall that allow the wall to be more complete and denser, which will slow 
down the release rate of the drug as it has been observed with ethylcellulose 11 •85 and 
chitin9 microcapsules in the release of theophylline and 6-mercaptopurine respectively. 
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II. OBJECTIVES 
Cellulose acetate butyrates are hydrophobic cellulose derivatives. They are available in 
the molecular weight ranges changing from 53,000 to 265,000 with varying acetyl, 
butyryl and hydroxyl contents. The difference in the molecular weights provides an 
advantage to study the effects of molecular weight and the substitution groups contents 
on the general properties of microencapsulated materials. 
The objective of this study was to determine the effects of molecular weight, acetyl, 
butyryl and hydroxyl contents on surface characteristics, yield, mean particle size, 
particle size distribution, drug loading, degree of aggregation and release characteristics 
of ascorbyl palmitate microcapsules. The microcapsules prepared with various cellulose 
acetate butyrates by using three different molecular weight fractions of cellulose acetate 
butyrate with varying substitution group contents. 
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III. EXPERIMENTAL 
3.1 MATERIALS AND INSTRUMENTS USED 
All the chemicals used in this studies are listed in Table ill. Ascorbyl palmitate, which 
is the model drug encapsulated, is described in 3.1.1 and cellulose acetate butyrate in 
3.1.2. 
3.1.1 Ascorbyl Palmitate 
Ascorbyl palrnitate is a white crystalline powder. The structure of ascorbyl palmitate is 
given in Figure 5. Its molecular weight is 414.54 g/mole, and the melting range is 
between 107-117°C. The bulk density of ascorbyl palrnitate is 8.7 lb/ft3. The specific 
rotation ( [o:]20 ) is between +21° and +24°. Ascorbyl Palmitate is soluble in ethanol, 
benzene, dioxane, ethyleneglycol, 2-ethoxyethanol, propyleneglycol and ethylacetate at 
25°C, but very slightly soluble in water93 . 
Ascorbic acid is one of the most effective water-soluble antioxidants. For that reason, it 
quickly oxidizes in water94. Ascorbyl palmitate is the palmitic acid ester of ascorbic 
acid which is a more stable antioxidant than ascorbic acid in the aqueous medium. In 
cosmetics, ascorbyl palmitate is mainly used as an antioxidant and a skin-lightening 
agent which inhibits tyrosinase activity during melanin synthesis. 
The amount and distribution of melanin produced by melanocytes primarily determines 
the skin color. Tyrosine is the starting material for melanin formation. Tyrosine 
32 
( Table III : List of Chemicals 
CHEMICALS LOT NO. MANUFACTURES 
Cellulose Acetate Butyrate 553-0.4 AD-5469B Eastman Chemical Company 
Kingsport, TN 37662-5280 
Cellulose Acetate Butyrate 381-0. l BG-7159B 
Cellulose Acetate Butyrate 531-1 AV-9821B 
Cellulose Acetate Butyrate 381-2 KR-9587B 
Cellulose Acetate Butyrate l 7 l- l 5S B-23174 
Cellulose Acetate Butyrate 381-20 C-1675E 
Butylated Hydroxytoluene (BHT) 60101 
Ascorbyl Palmitate 5060649 Roche Vitamins & Fine Chemicals 
Nutley, NJ 07110 
Acetone 963777 Fisher Chemical 
Fair Lawn, NJ 07410 
, 
~-~ Hexane 965941 
Magnesium Stearate EU4149 Witco Corporation 
Houston, Texas 77053 
Mineral Oil 79804 
Span 60 24588L ICI Surfactants 
Wilmington, DE 19850 
Span 80 34315 
Sodium Thiosulfate Aldrich Chemical Co., 
Inc. 
Milwaukee, WI 53233 
Polyvinylpyrrolidone 04-0398 BASF Corporation 
Parsi1212ani'., NJ 07054 
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Figure 5 : Chemical Structure of Ascorbyl Palmitate 
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undergoes an oxidative reaction to form dopaquinone which spontaneously converts to 
melanin. The conversion process of tyrosine to dopaquinone needs a copper-containing 
enzyme, tyrosinase, which plays an important role in melanin synthesis95-98 . This 
reaction is shown in Figure 6. When tyrosinase activity is inhibited, melanin cannot 
form. Most cosmetic products claiming skin-lightening effects contain tyrosinase 
inhibitors, such as hydroquinone, arbutin, placental extract, kojic acid and ascorbic acid 
deri vati ves99· 100 . 
Compared to other tyrosinase inhibitors, ascorbic acid and its derivatives appear to be 
effective, economical and safe to use. However, the inhibitory effect of ascorbic acid 
cannot be maximized due to its highly unstable nature. It quickly decomposes to 
hydroxy ascorbic acid in an aqueous medium, which does not have the same effect as 
ascorbic acid. 
Among several ascorbic acid derivatives, palmitate ester is one of the most widely used 
tyrosinase inhibitor because, compared to other derivatives of ascorbic acid, it is 
relatively stable, hydrophobic and acts as a pro-drug. It was found that its skin 
penetration ability was much higher than ascorbic acid94. Therefore it was selected as 
the model drug for this thesis study. 
3.1.2 Cellulose Acetate Butyrate 
Cellulose acetate butyrates are hydrophobic cellulose derivatives. Their specific gravity 
varies between 1.16 to 1.26. Depending on the substitution groups, the viscosity, 
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glass transition temperature and the melting points of similar molecular weight fractions 
also vary. Cellulose acetate butyrate dissolves in acetone, ethyl acetate and methylene 
chloride. It is not soluble in water. The structure of cellulose acetate butyrate is shown 
in Figure 7. Depending on the acetyl , butyryl and hydroxyl groups content as shown in 
Table IV, the physical and chemical properties of the cellulose acetate butyrate may 
vary. 
As seen in Table IV, the viscosity of cellulose acetate butyrate in acetone increases as 
the molecular weight of the polymer increases. Besides polymer molecular weight, the 
higher hydroxyl content is likely to be influential in the viscosity. The CAB 531-1 and 
CAB 381-2 have very similar hydroxyl content. In this case, it appears that the higher 
butyryl content of CAB 531-1 increases the solubility of the polymer in acetone and 
provides slightly lower viscosity. 
The polydispersity of cellulose acetate butyrate fractions used for microencapulation 
seem to be slightly increasing with the increasing polymer molecular weight. However, 
the difference between the molecular weight fractions around 60,000 Da and 160,000 
Da does not appear to be very different. 
3.2 INSTRUMENTS USED 
The instruments used in this study are listed in Table V. 
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Figure 7 : Chemical Structure of Cellulose Acetate Butyrate 
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Table IV : Specification of Cellulose Acetate Butyrate 
Substitution Groups (%w/w in overall Mw) 
Polymer Mw* Viscosity Tg Tm Polydispersity Acetyl Butyryl Hydroxyl 
Batch No. (Dalton) (6%w/w sol.)** (oC) (oC) Content(%) Content(%) Content(%) 
(cP) 
CAB 381-0.1 53937 1.97 123 155-165 3.111 13.5 38.0 1.3 
CAB 553-0.4 67840 3.16 136 150-160 3.248 2.0 46.0 4.8 
w 
'° CAB381-2 155437 11.31 133 171-184 3.208 13.5 38.0 1.3 
CAB 531-1 171439 11.19 115 135-150 3.404 3.0 50.0 1.7 
CAB 171-15S 216380 49.94 161 230-240 3.844 29.5 17.0 1.1 
CAB 381-20 264362 51.45 141 195-205 4.402 13.5 37.0 1.8 
* The mean molecular weights shown in Table ill were provided by Eastman Chemical Company. The values were obtained 
by Gel Permeation Chromatography (GPC). 
** As measured by a Ubbelholde viscometer as 6% of the polymer in acetone. 
• The substitution groups contents were provided as the percentage of the overall molecular weights . 
Table V: Instruments Used in This Study. 
INSTRUMENTS MODEL MANUFACTURES 
Olympus Image Analyser CH507494 Olympus Optical Co., Ltd 
Tokyo, Japan 
Compact Photo PM-6 Olympus Optical Co., Ltd 
Micrographic Equipment Tokyo, Japan 
PH-meter 811 Orion Research, Inc. 
Cambridge, Massachusetts 
Micromaster Microscope CK Fisher Scientific Company 
Fairlawn, NJ 
Sony Trintron Color PVM-113420 JAVA Video Analysis ( 
, Video Monitor Software, Jandel Scientific, 
/ 
~ ·/ 
CA 
UV-Visible Hew lettpackard Hewlett-Packard Company, 
Spectrophotometer 8451A Diode Corvallis, Oregon 
UV-Visible Perfector Scientific 
Spectrophotometer Cell Atoscadero, CA 93423 
Scanning Electron Microscope DX-E30S Akashi Beam 
Technology, Tokyo 
180, Japan 
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( Table V (continuation) 
INSTRUMENTS MODEL MANUFACTURES 
Mettler Balance AE240 Northest Blance 
Service Middletown, 
Conn.06457 
Electronic Analytical 1601 MP8 Subron-Brinkman 
Balance Sartorius Instruments Co. 
Westbury, NY 
Central Scientific Sieve Van-Kel Industries, 
Shaker Inc. Chatham, NJ 
07228 
Ultrasonic Cleanser TIOO National Ultrosonic 
; __ .,,,. Corp. Irvington 11, NJ 
YAMATO Constant BT-25 YAMATO Scientific 
Temperature Shaking Co. Ltd., Japan 
Bath 
Ubbelholde Viscometer Ki max 
Tube 
Fisher Dyna-Mix 60900285 Fisher Scientific, 
Pittsburgh, PA 15219 
Disposable Scintillation Vials 20mL Kimble Glass, Inc. 
Vinelane, NJ 08360 
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3.3 METHODOLOGY 
3.3.1 Determination of the Viscosity of Cellulose Acetate Butyrate Solution 
The viscosity of cellulose acetate butyrate in acetone was measured by using 
Ubbelholde Viscometer Tube (Kimax, J 36, size 350). 60ml cellulose acetate butyrate 
solution (6%w/w, in acetone) was placed in the viscometer, viscosity was measured by 
timing the flow time of the liquid between the two marks. Compared to the viscosity of 
water (1.004 cs, 20°C), the viscosity of the polymer solution was obtained by using 
Equation (1): 
TJ = p X (tpftw) X 1.004 ............................... (1) 
where TJ is the viscosity of the polymer solution in centistokes, p is the density of the 
polymer solution (g/cm3), tp and tw are the flow time between the marked points of the 
viscometer (in seconds) of the polymer solution and water, respectively. The data 
obtained are listed in Table VI. 
3.3.2 Analytical Determination of Ascorbyl Palmitate 
Ascorbyl Palmitate is a hydrophobic drug. Its general properties were described in 
Section 3.1. l. It is poorly soluble in water. Since release studies were to be carried out 
in the aqueous medium, an analytical method to determine ascorbyl palmitate in water 
was developed. 
42 
( 
Table VI: Viscosity of the 6% w/w Cellulose acetate Butyrate in Acetone. 
Polymer Mw Flow Time Viscosity ( cP) (n=3) 
Batch No. (Dalton) (seconds) (11 = 0.81 X (tp/tw) X 1.004) 
381-0.1 53937 23.15 1.97 
553-0.4 67840 14.43 3.16 
381-2 155437 82.87 11.31 
531-1 171439 82.04 11.19 
171-15S 216380 363.61 49.94 
381-20 264362 376.47 51.45 
Water 5.95 
• tp and tw are the time required for the polymer solution and water to pass 
through the two marks on the viscometer tube, respectively. 
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Ascorbyl Palmitate in water shows two characteristic absorption peaks at /.., = 204 and 
262 nm, Figure 8A. The absorbance at /.., = 204 nm would be easily affected by 
interference from other chemicals used in this study, like cellulose acetate butyrate, and 
our preliminary experiments demonstrated that it was less sensitive to oxidative 
changes that takes place in the molecule. The absorbance at /.., = 262nm is sensitive to 
oxidative changes and quickly disappears by oxidation, Figure 8B. 
In Figure 8, the ascorbyl palmitate concentration used was 0.1658 g/L. The original 
intensity of ascorbyl palmitate at this concentration at A.262 was 0.5271, it decreased to 
0.2875 over 24 hours in deionized water. Therefore A.2"d max was used to follow 
oxidative stability of ascorbyl palmitate for solubility and release studies. In order to 
maintain stability during the release rate measurements, l .5%w/w sodium thiosulfate 
was added to the solution. 
The stability of ascorbyl palmitate was verified by UV analysis. In the presence of 
sodium thiosulfate, the 'A2"d.max moved from 265 to 270 nm. The stability of sodium 
thiosulfate was followed for 72 hours by measuring the intensity of A.2"d.max. Table VII. 
3.3.3 Calibration of Ascorbyl Palmitate for UV Analysis 
Ascorbyl palmitate (2 mg) was dissolved in 50 ml water which contained 1.5% sodium 
thiosulfate. An appropriate volume ( 1, 2, 3, 4, 5, 6 and 8 ml) of this solution was 
transferred to seven I 0 ml volumetric flasks respectively and made up 
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Figure 8 : UV Profile of Ascorbyl Palmitate in Deionized Water. 
The Ascorbyl Palmitate Concentration is 0.1658 g/L. 
((A) : measured right after preparation: (8) : measured 24 
hours after preparation.) 
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Table VII : Absorbances of Ascorbyl Palmitate in Deionized Water in the 
Presence of 1.5%w/w Sodium Thiosulfate Used as an 
Antioxidant. (}..z70, c = 0.1658g/L} 
Time (hr) Batch 1 Batch 2 Average 
0 0.354507 0.370128 0.362318 
24 0.348857 0.367302 0.358080 
48 0.341537 0.368842 0.355190 
72 0.365661 0.372044 0.368853 
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to 10 ml with the dissolution medium. The concentrations thus obtained were 
0.004,0.008, 0.012, 0.016, 0.02, 0.024, 0.032 and 0.04 mg/ml. Using the dissolution 
medium as a blank, the absorbances were measured at 270 nm in four replicate 
solutions. Figure 9 demonstrates that the results obtained obeyed Beer's Law between 
0.005 and 0.040 g/L ascorbyl palmitate concentrations. 
3.3.4 Solubility Determination of Ascorbyl Palmitate 
To determine the solubility of the ascorbyl palrnitate, 1 gm ascorbyl palrnitate was 
added to 50ml deionized water which contained 0.75 gm sodium thiosulfate as an 
antioxidant. The suspension was shaken for 72 hours in a water bath at 37°±0.5°C. 
Then the drug was filtered from No.2 filter paper. The supernatant was diluted and 
analyzed by UV spectrophotometer at the wavelength of 270nm.24 This procedure was 
repeated four times. The solubility of ascorbyl palmitate in water containing l .5%w/w 
sodium thiosulfate was found as 0.9342 ± 0.0434 g/L. The related data were given in 
Appendix I, Table I. 
3.3.5 Preparation of Microcapsules 
The emulsion non-solvent addition method of Sprockel and Prapaitrakul 18 was used for 
microcapsule preparation. The details of the method and its outcome was discussed in 
Sec 1.3.6. Based on the findings mentioned in Sec 1.3.6, in this study, low polymer to 
solvent concentration (6%), low drug to polymer ratio (1/2) and high stirring rate 
(2000rpm) was used to obtain small microcapsules.31 .47 
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The total amount of the ingredients added and order of microcapsule formation is 
described in Figure 10. For microencapsulation formation, the polymer (0.6 g), ascorbyl 
palmitate (0.3 g) and butylated hydroxytoluene (BHT, 0.01 g) were dissolved in acetone 
(9.4 g). The oil phase used was 88 . lg light mineral oil that contained O. lg BHT, 0.9g 
Span and 0.9g magnesium stearate. Selection between Span 60 and Span 80 which were 
used in 0.2 and 1 % concentrations was made earlier by comparing the data obtained 
with both surfactants by a statistical analysis in order to create the largest differences 
between the highest and lowest molecular weight coated cellulose acetate butyrate. 
(Please see Appendix II for details.) Accordingly Span 80 at 1 % concentration was 
selected for microcapsule preparation. 
Cellulose acetate butyrate, ascorbyl palmitate and BHT were dissolved in acetone and 
the mixture was poured into oil phase while being stirred at 2000 rpm with a Fisher 
Dyna-mixer (Fisher Scientific, Pittsburgh, PA) at ambient temperature. The emulsion 
formed was stirred at the same speed for another 15 minutes. Hexane (30 mL), which 
hardened the emulsion droplets, was added to this emulsion drop by drop at the rate of 
1.5 ml/min. The particles thus hardened were then filtered and washed by 60 ml of 
hexane in four portions to remove the remaining mineral oil. They were dried on the 
filter paper in a dark and cool place. Each batch was prepared in quadruples. 
3.3.6 Characterization of the Microcapsules 
3.3.6.1 mean particle size, size distribution and degree of aggregation 
The mean particle size and the size distribution of the particles were determined and 
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Cellulose Acetate Butyrate (0.6g) 
+ Ascorbyl palmitate (0.3g) 
Magnesium Stearate (0.9g) 
+ Span 80 (0.9g) 
+ BHT (O.Olg) + BHT (0.lg) 
l Acetone (9 .4g) 
CAB Solution 
l Mineral Oil (88. lg) 
Oil Phase 
Acetone/Oil Emulsion 
l Hexane (30rnL), Solidification of the Spheres 
Microcapsules 
1 
Filtration 
l Hexane (60rnL), Washing Liquid 
Final Product 
Figure 10 : Flow Chart of Preparation of Ascorbyl Palmitate Microcapsules 
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characterized by an image analyzer (Olympus Image Analyser, CH507494, 
Olympus Optical Co., Ltd., Tokyo, Japan). Microcapsules (20 mg) were placed in 
an 20ml screw-capped glass vial which contained 15ml deionized water and 0.3g 
polyvinylpyrrolidone which was used as the dispersant. Prior to measurements, the 
suspension was deaggregated in an ultrasonic bath (Ultrasonic Cleanser, TIOO, 
National Ultrosonic Corp. , Irvington 11, NJ) for 2 minutes. 
This dispersion was used under the microscope. The diameters of at least 740 
particles were measured in order that the mean particle size obtained was 
representative of the batch prepared within 95% confidence level. The means and 
standard deviation were calculated by using Excel. 
The degree of aggregation was calculated by counting the number of aggregated 
particles that were present in 740 particles and calculating the percentage. 
3.3.6.2 microscopical appearance 
Surface morphology of the microcapsules were observed by a scanning electron 
microscope(DX-E30S, ABT Co., Tokyo, Japan). In order to determine the surface 
morphology of the particles, the microcapsules were first dispersed in alcohol and 
were transferred to a metallic round disk. After evaporation of the alcohol, the 
sample was coated with gold in a coating chamber(SC 502, ABT Co., Tokyo, 
Japan) . Scanning electron micrographs were then taken. 
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3.3.6.3 determination of drug loading 
Methylene chloride is a good solvent for cellulose acetate butyrate but does not dissolve 
ascorbyl palmitate. Therefore ascorbyl palmitate content of the microcapsules was 
measured by using methylene chloride. For this purpose, I Omg microcapsules was 
placed in a 100 mL volumetric flask containing 25 mL methylene chloride. The flask 
was shaken manually to completely dissolve cellulose acetate butyrate, then the 
ascorbyl palmitate particles that remained in the suspension were filtered. The particles 
collected on a filter paper were further washed with 25 ml methylene chloride to assure 
complete dissolution of cellulose acetate butyrate and dried in cool open air in a dark 
room. The particles left on the filter paper were dissolved in 10 ml dissolution medium 
(deionized water + 1.5% sodium thiosulfate) and the absorbance of the solution was 
measured by UV spectrophotometer at 270 nm to determine the ascorbyl palmitate 
content of the microcapsules. 
3.3.6.4 release studies 
The microcapsules were sieved by using two standard sieves (75-90um and 90-l 77um) 
on a sieve shaker (Central Scientific Sieve Shaker, Van-Kel Industries, Inc. Chatham, 
NJ) for 5 minutes, then the microcapsules with the diameter ranging from 75 to 90 um 
were collected and subjected to the release studies. The dissolution medium selected for 
release studies was composed of deionized water and 1.5% (w/w) sodium thiosulfate. 
The release characteristics of ascorbyl palmitate was determined by dispersing 5mg 
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microcapsules (75-90 um) in 50ml dissolution medium which was kept in a IOOml 
screw-capped glass vial and placed in a water bath shaker (YAMATO Constant 
Temperature Shaking Bath, BT-25, YAMATO Scientific Co. Ltd., Japan) at 37 ± 
0.5°C. Samples (2ml) were withdrawn at I, 2, 4, 6 and 8 hours time intervals, and were 
filtered and analyzed by UV spectrophotometer at 270nm. Fresh dissolution medium 
(2ml) equal to the amount that was withdrawn was immediately introduced into the 
dissolution vials after each sampling in order to maintain sink conditions. 
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IV RESULTS AND DISCUSSIONS 
4.1 MICROSCOPIC APPEARANCE 
The size of rnicrocapsules increased with the increase in polymer molecular weight. The 
scanning electron microscopic pictures of the microapsules produced with low and high 
molecular weight polymers (53,937 and 216,380 Daltons) are given in Figure 11. The 
microcapsules seemed to be round-shaped and the surface appearance do not seem to 
have obvious difference between them. However, there is substantial surface 
precipitation. 
4.2 1HE EFFECTS OF POLYMER PROPERTIES ON MICROCAPSULES 
PERFORMANCE 
The results of polymer viscosity in acetone, yield, mean particle size, size distribution, 
drug loading and degree of aggregation of the rnicrocapsules produced with the 
corresponding polymers are listed in Table VID and the original data are given in 
Appendix I, Table II. The formulation responses obtained were further drawn against 
each molecular variable, including molecular weight, solution viscosity and 
polydispersity of the polymer. Figures 12-14 demonstrate that the yield tends to 
increases with decreasing polymer molecular weight and solution viscosity. The mean 
particle size and size distribution of the microcapsules tend to increase with the 
increasing molecular weight, solution viscosity and polydispersity. 
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Figure 11 : Scanning Electron Micrographs of Cellulose Acetate 
Butyrate l\:licrocapsules Containing Ascorbyl 
Palmitate. (Microcapsules produced with (A) CAB 
(53937 Da): (B) : CAB (216380 Da). 
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Table VIII : Properties of Cellulose Acetate Butyrate Coated Microcapsules. 
Polymer Properties 
Mw Acetyl Butyryl Hydroxyl Solution Poly - Yield 
(Daltons) Content Content Content(%) Viscosity dispersity (%) 
(%) (%) (cP) (um) 
53937 13.5 38.0 1.3 l.97 3.111 98.17±1.55 
67840 2.0 46.0 4.8 3.16 3.248 99.03±1.31 
155437 13.5 38.0 1.3 11.31 3.208 96.25±2.54 
171439 3.0 50.0 1.7 11.19 3.404 97.03±2.70 
216380 29.5 17.0 1.1 49.94 3.844 95.14±2.19 
264362 13.5 37.0 1.8 51.45 4.402 94.59±1.66 
* Each batch was prepared four times. 
Microcapsules Properties 
Mean Size Degree of Drug 
Particle Distribution Aggregation Loading 
Size (um) (%) (%) 
(um) 
24.41±1.90 7.47±0.60 19.16±1.21 11.89±0.96 
24.10±3.36 9.80±0.82 12.50±0.69 12.30±2.25 
49.75±2.28 17.31±2.43 13.34±1.11 12.00±1.42 
38.19±3.44 11.52±1.46 11.02±1.70 11.23± 1.13 
57.14±4.67 18.64±1.51 9.34 ±l.40 8.16±1.23 
46.99±2.56 19.85±2.40 9.61±0.91 10.86±1.70 
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The degree of aggregation decreases with the increase in polymer molecular weight, 
solution viscosity and polydispersity. 
Although molecular weight stands out as the most significant variable, Figures 12-14 
demonstrated that neither the molecular weight nor the solution viscosity and 
polydispersity was the single cause of the microcapsules characteristics. Therefore the 
best treatment would be to seek the combined effects of molecular weight, solution 
viscosity and polydispersity of the polymer via statistical treatments. 
The Stepwise Regression Analysis was the statistical method used to determine the 
significant variables affected the overall properties of the microcapsules. It is based on 
the comparison of the R-square of each variable. The greater the R-square the variable 
contribute to the regression, the more important the variable becomes. By using 
Stepwise Regression Analysis, first the effects of the acetyl, butyryl and hydroxyl 
groups, molecular weight, viscosity of the polymer solution and polydispersity were 
sought, Table IX. 
From Table IX, the viscosity of the cellulose acetate butyrate solution was found to be 
affected most significantly by first the polymer molecular weight, then the butyryl 
content, third; by the hydroxyl content. The viscosity of the polymer increased with 
increasing molecular weight and hydroxyl content, decreased with the increase in 
butyryl content. The relationship between the three variables can be described by 
Equation (2): 
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Table IX : The Relationships Between the Chemical Structure of Cellulose Acetate Butyrate on the Molecular 
Viscosity and Polydispersity as Determined by Stepwise Regression Analysis 
POLYMER CHARACTERISTICS 
Molecular Weight Acetyl Content Butyryl Content Hydroxyl Content 
(Dalton) (%) (%) (%) 
Responses 
Viscosity (cP) 0.000 (1st) NS 0.000 (2"d) 0.004 (3rd) 
Polydispersity 0.000 (ls1) NS NS 0.032 (2"d) 
The numbers shown in the table were p-values which were only given when the variables were significant. 
* The ranking given in the parenthesis were the order of the influence of the polymer properties on the response 
which were calculated by Minitab Stepwise Regression Program. 
NS : Not significant 
--.... 
I 
I 
, ... ...... 
/ 
11 = 15.3 + 0.000222 Mw - 0.930 <!>ti+ 3.39 <!>ti .. .. . ..... (2) 
where 11 is the viscosity (cP), Mw is the polymer molecular weight (Da), <!>ti is the 
butyryl content (%) and <!>ti is the hydroxyl content (%). (The detailed statistical data 
obtained are given in Appendix I, Table III.) 
On the other hand, the polydispersity of the polymer was affected by only the molecular 
weight of the polymer and hydroxyl group content, Table IX. The molecular 
polydispersity increased with increasing polymer molecular weight and hydroxyl 
content, Appendix I, Table IV. The relationship between the polydispersity, molecular 
weight and hydroxyl content can be described by Equation (3): 
ro = 2.44 + 0.000006 Mw + 0.0851 <!>ii •• ••• ••• ••• ••••••.... (3) 
R2 = 0.82 
where ro is polydispersity of cellulose acetate butyrate and <!>ti is the percent hydroxyl 
content of the molecule. 
Since the substitution groups and the molecular weight significantly affected the 
solution viscosity and molecular polydispersity and those are the physical chemical 
factors that are effective during microcapsules formation, the effects of molecular 
weight, molecular polydispersity and solution viscosity on the formulation variables 
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such as the yield, mean particle size, size distribution, degree of aggregation and drug 
loading were sought the next, Table X. 
The p-values and R-squares obtained in Table X demonstrated molecular weight of the 
polymer affected all physical-chemical properties of the microcapsules except drug 
loading. The acetyl content affects only mean particle size. Butyryl content has the 
influence over drug loading. Hydroxyl content affects only degree of aggregation. 
4.2.1 Effects of Polymer Molecular Weight, Polydispersity and Solution Viscosity on 
the Yield 
The yields of the microcapsules produced with six polymers were shown in Table Vill. 
Table X demonstrated that the only significant variable which has influence on yield is 
the polymer molecular weight. Microcapsule yield decreased as the polymer molecular 
weight increased. Since molecular weight is the only significant factor, its effect on the 
yield can be shown on a XY graph, Figure 15. The detailed statistical data was given in 
Appendix I, Table V. 
4.2.2 Effects of Polymer Molecular Weight, Polydispersity and Solution 
Viscosity on the Mean Particle Size, Size Distribution and Degree of 
Aggregation 
Table X also demonstrated that all the three variables have effects on the inean 
microcapsule size. Polymer molecular weight is the most dominant factor, mol.ecular 
polydispersity is the second and the solution viscosity is the third. The detailed 
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Table X : The Significant Relationships Between the Molecular Characteristics of Cellulose Acetate Butyrate 
and Physical Chemical Properties of the Microcapsules as Determined by Stepwise Regression 
Analysis 
POLYMER CHARACTERISTICS 
Molecular Weight Solution Viscosity Molecular 
(Dalton) (cp) Polydispersity 
Responses 
Yield 0.001 NS NS 
Mean Particle Size 0.000 (1 51) 0.000 (3rd) 0.000 (2"d) 
Size Distribution 0.000 NS NS 
Degree of Aggregation 0.000 NS NS 
Drug Loading NS 0.003 (1 51) 0.036 (2"d) 
The numbers shown in the table were p-values which were only given when the variables were significant. 
*The ranking given in the parenthesis were the order of the influence of the polymer properties on the response 
which were calculated by Minitab Stepwise Regression Program 
NS : Not significant 
,,.---...., 
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statistical analysis data are given m Appendix I, Table VI. Generally the size of 
rnicrocapsules increased with increasing molecular weight and solution viscosity, but 
decreased with increasing polydispersity. The relationship between the properties of the 
polymer and the mean particle size can be described by Equation (4). 
d = 137 + 0.000185 Mw - 39.7co + 0.66811 ...... . . . ........... (4) 
R2 = 0.93 
where d is mean particle size (urn), Mw is polymer molecular weight (Da) co is 
molecular polydispersity and 11 is the solution viscosity ( cP). 
From Table X, molecular weight stood out as the only significant factor that affected 
particle size distribution of the rnicrocapsules. Details of the analysis was given in 
Appendix I, Table VII. Higher molecular weight cellulose acetate butyrate produced 
rnicrocapsules with wider particle size distribution. The effect of polymer molecular 
weight on size distribution is shown in Figure 16. The relationship of regression can be 
described by Equation (5). 
cr = 5.02 + 0.000060 Mw ............. . . . ..... . ......... . ... . .... (5) 
R2 =0.75 
where cr is the particle size distribution (urn) and Mw is the molecular weight. 
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Figure 16 : distribution vs Mw 
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Figure 16 : Effect of Molecular Weight on Particle Size 
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Among polymer molecular weight, polydispersity and solution viscosity, only the 
molecular weight of the polymer significantly affected the degree of aggregation, Table 
X, Appendix I, Table Vill. The degree of aggregation significantly decreases as the 
polymer molecular weight increases. The solubility of higher molecular weight polymer 
in solvent was less than that of lower molecular weight polymer. Therefore, the heavier 
polymer would precipitate out faster and the molecular chain would be hardened by not 
allowing the intermolecular interaction of the cellulose acetate butyrate layers around 
the particles wbich would cause aggregation. The effect of polymer molecular weight 
on the degree of aggregation is shown in Figure 17. 
4.2.3 Effects of Polymer Molecular Weight, Polydispersity and Solution Viscosity on 
Drug Loading 
Both the solution viscosity and molecular polydispersity significantly affect drug 
loading, Table X, Appendix I, Table IX. Solution viscosity is the most important factor 
and the polydispersity is the second. Drug loading increases with lower viscosity of the 
polymer solution, but decreases with the increasing molecular polydispersity. 
4.2.4 Release of Ascorbyl Palmitate from Cellulose Acetate Butyrate Coated 
Microcapsules 
Release profiles of the ascorbyl palmitate from cellulose acetate butyrate microcapsules 
is shown in Figure 18 where the smallest molecular weight polymer appear to provide 
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the fastest release than the higher molecular weight fractions . From Figure 18, the total 
amounts released at the end of the first hour and eight hours do not seem to be 
statistically different from one another. 
HIGUCHI Model, Zero Order and First Order release models 105-108 were frequently 
used models to describe release and dissolution of drugs from microcapsules. The 
HIGUCHI Equation is shown in Equation (6). 
M = kt 112 •••••••••••••••••••••••••••••••••••••••••••••••• (6) 
where M is the percent release, k is release rate constant and t is the time of release. 
The Zero Order Equation is : 
M =kt .................................................. (?) 
The First Order Equation is : 
M = 1 - e-kt ............................................. (8) 
The graphs given m Figure 18 demonstrated two different release rates for the 
microcapsules prepared with different molecular weight fractions. Within 0-1 hour a 
"burst effect" was observed then the release was at a steady state. 
"Burst effect" was due to the release of the drug adsorbed on the microcapsule surfaces. 
From Figure 11, the presence of substantial surface precipitate is apparent. Release 
studies were carried out without further purification. 
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( Burst release was also reported in several previous publications57· 101 . In the study of 
Jalil and Nixon's57 , burst effect was observed when phenobarbitone released from 
polylactic acid microcapsules, and it was not significantly affected by the molecular 
weight variations of the poly lactic acid. Similar profiles were also obtained by Igartua et 
al. 101 and O'Hagan et aJ. 102 who both studied the release of albumin from poly(lactide-
co-gl ycolide) microspheres. 
The steady state release data obtained were applied to HIGUCHI, Zero Order and First 
Order Equations. Table XI demonstrates the fit of the data to HIGUCHI, Zero Order 
and First Order models. From Table XI, it is clearly seen that the steady state release of 
ascorbyl palmitate from cellulose acetate butyrate mcrocapsules fits both HIGUCHI and 
Zero Order models equally well. However, microcapsules produced with 216,380 and 
264,362 Da polymers began to have some deviation from the Zero Order Release. 
Therefore, the HIGUCHI model was used to calculate the burst release and steady state 
release rate. The burst release was determined by the extrapolated values of the 
HIGUCHI fit at 0 hour. Table XII. 
The data of the burst release, steady state release and total release in one and eight hours 
were analyzed by Stepwise Regression Analysis to find out the significant variables that 
could affect the release performance. The results are given in Table XIII. 
The burst release was demonstrated to be related to first the solution viscosity and. then 
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Table XI : Correlation Coefficient of the HIGUCHI, Zero Order and First Order Fits of the 
Steady State Release Profiles of the Cellulose Acetate Butyrate Fractions 
Batch Name Molecular Weight R2 R2 R2 
(Daltons) (HIGUCHI) (Zero Order) (First Order) 
CAB 553-0.4 67,840 0.9877 0.9932 0.9170 
CAB 381-0.1 53,937 0.9978 0.9888 0.9675 
CAB 531-1 171,439 0.9925 0.9956 0.9378 
CAB381-1 155,437 0.9972 0.9927 0.9750 
CAB 171-15S 216,380 0.9843 0.9426 0.9876 
CAB 381-20 264,362 0.9826 0.9634 0.9831 
Average 0.9904 0.9794 0.9613 
....---..., 
Table XII : Total Amount Release in 1 and 8 hours and Steady State Release Rate of Ascorbyl Palmitate Microcapsules 
Polymer Properties Release Properties of Microcapsules 
Mw Acetyl Butyryl Hydroxyl Solution Poly - Burst Total Release Total Release Steady State 
(Daltons Content Content Content Viscosity dispersity Release at 1 Hour in 8 Hours Release Rate 
) (%) (%) (%) (cP) (um) (ex, %) (%) (%) 
53937 13.5 38.0 1.3 1.97 3.111 0.4625 63.02±3.71 94.11±2.64 0.1666 
67840 2.0 46.0 4.8 3.16 3.248 0.4881 65.03±4.48 94.96±2.64 0.1580 
-.....) 
~ 
155437 13.5 38.0 1.3 11.31 3.208 0.3585 55.13±4.73 89.94±4.89 0.1879 
171439 3.0 50.0 1.7 11.19 3.404 0.4502 62.74±8.07 93.73±2.82 0.1675 
216380 29.5 17.0 I. I 49.94 3.844 0.2082 38.83±10.20 77.42±3.52 0.2025 
264362 13.5 37.0 1.8 51.45 4.402 0.3597 50.28±6.26 78.94±9.39 0.1524 
* Each batch was prepared four times and tested for release. 
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Table XIII : Significance of the Molecular Weight, Polydispersity and Viscosity of the Polymer on the 
Release Characteristics of the Microcapsules 
POLYMER CHARACTERISTICS 
RELEASE CHARACTERISTICS 
OF MICROCAPSULES 
Burst Release 
Steady State Release 
Total Release in 1 hr 
Total Release in 8 hrs 
Molecular Weight 
(Dalton) 
NS 
NS 
NS 
0.000 (1st) 
Solution Viscosity 
(cp) 
0.000 (1st) 
NS 
0.000 (1st) 
NS 
Polydispersity 
0.008 (2"d) 
NS 
0.004 (2"d) 
0.002 (2"d) 
The numbers shown in the table were p-values which were only given when the variables were significant. 
* The ranking given in the parenthesis were the order of the influence of the polymer or microcapsule properties on 
the response which were calculated by Minitab Stepwise Regression Program 
~"' 
( 
( 
the polydispersity of the polymer by using Stepwise Regression Analysis, Table Xill. 
Burst release is lower with higher viscosity of the polymer solution and smaller 
polydispersity. 
The Least Significant Difference(LSD) Test is a statistical method to determine whether 
the difference between the arguments is significant by comparing the difference to the 
calculated LSD value, the arguments are significantly different if the difference is larger 
than the LSD value. From the LSD Test, there is no significant difference of the burst 
release between the polymers except for the one with molecular weight 216,380 Da 
which shows the lowest burst release. The detailed statistical data were given in 
Appendix I, Table X. 
The data of steady state release given in Table XII show no significant differences 
between the six polymers. The observation was demonstrated by LSD Test, Appendix I, 
Table XI. Therefore, the steady state release of the six polymers was not different from 
one another and was not affected by the physical-chemical properties of the polymer. 
The total release in one hour was affected by first the solution viscosity and then the 
polydispersity of the polymer, Table Xill. The total release in one hour increases with 
decreasing solution viscosity and increasing polydispersity. The detailed statistical data 
were given in Appendix I, Table XII. 
The total release in eight hours was only influenced by the viscosity of the polymer 
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solution, Table Xill. The total release in eight hours increases with decreasing solution 
viscosity, Appendix I, Table Xill. 
Overall, cellulose acetate butyrate with varying molecular weights affected ascorbyl 
palmitate microcapsules in more than one way. There were all acceptable fine flowing 
microcapsules and depending on the primary purpose of the microcapsules, a suitable 
batch of cellulose acetate butyrate can be selected in order to satisfy formulation 
requirements. 
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( V. CONCLUSION 
The ascorbyl palmitate microcapsules produced by six different cellulose acetate 
butyrate fractions with mean molecular weight of 53,000 to 265,000 were acceptable 
spherical particles with particle sizes changing from 24.10 to 57 .14um. Emulsion non-
solvent microencapsulation method was used for microcapsule production. 
The viscosity of the cellulose acetate butyrate solution (6% in acetone) that was used 
for microencapsulation was affected by the molecular weight, the butyryl and the 
hydroxyl content of the polymer in the given order. The solution viscosity increased 
with increasing molecular weight and hydroxyl content, but decreased with an increase 
in the butyryl content. 
The Stepwise Regression Analysis carried out demonstrated that the polydispersity of 
the polymer was also influenced by the polymer molecular weight and hydroxyl group 
content. The polydispersity increased with increasing polymer molecular weight and 
hydroxyl content. 
The microcapsule yield prepared with six fractions of cellulose acetate butyrate was 
influenced by the polymer molecular weight. Microcapsule yield decreased as the 
polymer molecular weight increased. 
Molecular weight, solution viscosity and the polydispersity of the polymer had 
significant effects on the mean particle size. The mean molecular weight was the most 
78 
( important factor which was followed by the solution viscosity and polydispersity. The 
size of microcapsules increased with increasing molecular weight, solution viscosity 
and decreased with increasing polymer polydispersity. 
The only significant factor that affected particle size distribution of the microcapsules 
was the molecular weight of the polymer. Higher molecular weight cellulose acetate 
butyrate produced microcapsules with wider particle size distribution. 
Degree of aggregation was only affected by the molecular weight of the polymer. The 
degree of aggregation decreased as the molecular weight of the polymer increased. 
Drug loading was significantly influenced by the solution viscosity and the 
polydispersity of the polymer in the given order. Higher viscosity of the polymer 
solution and narrower polydispersity of the polymer produced microcapsules with low 
drug loading. 
Statistical analysis of the release profiles demonstrated two different release rates of 
ascorbyl palmitate from the microcapsules which can be the result of the burst effect 
and steady state release. 
The burst release was affected by the solution viscosity of the polymer and its 
polydispersity. Basically, the burst release was lower with higher solution viscosity and 
smaller polydispersity of the polymer. 
The steady state releases of the polymers were not significantly different from one 
79 
( another. 
The total release in one hour was significantly influenced by solution viscosity and 
polydispersity. The amount of total release in one hour increased with decreasing 
solution viscosity and increasing polydispersity. 
The viscosity of the polymer solution was the only factor which affected the total 
release in eight hours. The total release in eight hours increased with decreasing 
viscosity of the polymer solution. 
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Table I : Solubility Data of Ascorbyl Palmitate in Deionized Water 
Containing 1.5 % Sodium Thiosulfate 
Repetition 1 2 3 4 
UV Absorbance 0.2022 0.2196 0.2095 0.1974 
Corresponding Solubility (g/L) 0.9118 0.9900 0.9448 0.8902 
Solubility : 0.9342 ± 0.0434 g/L 
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Table II : Properties of Cellulose Acetate Butyrate Coated Microcapsules. 
Polymer Mw Acetyl Butyryl Hydroxyl Viscosity Polydispersity Batch 
Brand No. (Daltons) Content Content Content (cP) 
(%~ !%~ !%~ 
38 1-0.1 53937 13.5 38.0 1.3 1.97 3.111 2.1 
2.2 
2.3 
2.4 
553-0.4 67840 2.0 46.0 4.8 3.16 3.248 I. I 
1.2 
1.3 
1.4 
381 -2 155437 13.5 38.0 1.3 11.31 3.208 4.1 
4.2 
4.3 
4.4 
531-1 171439 3.0 50.0 1.7 11.19 3.404 3.1 
3.2 
3.3 
3.4 
171-15S 216380 29.5 17.0 1.1 49.94 3.844 5.1 
5.2 
5.3 
5.4 
38 1-20 264362 13.5 37 .0 1.8 51 .45 4.402 6.1 
6.2 
6.3 
6.4 
~ 
Yield Mean Size Degree of Drug 
(%) Particle Distribution Aggregation Loading 
Size !um~ (um) !%) (%) 
98 .33 25 .57 7.25 20.70 11.43 
93 .89 21.96 6.76 18.99 13.32 
98 .33 23.88 7.69 19.22 11.40 
96.11 26.21 8.16 17.74 11 .40 
100.00 19.24 10.20 12.61 12.99 
97 .22 25.44 10.73 11 .76 14.40 
100.00 26.91 8.90 13.39 12.68 
98.89 24.81 9.37 12.22 9.1 2 
93.33 49.00 14.90 12.32 13.77 
96.67 46.99 16.06 14.86 12.17 
95.56 50.73 20.48 12.78 11.70 
99.44 52.28 17.81 13.40 10.34 
98.89 42.53 12.94 10.36 12.40 
97.78 38.24 11 .04 13.26 9.72 
95 .00 34.12 12.39 11 .20 11.19 
94.44 37.87 9.69 9.24 11.62 
94.44 62.29 20.88 8.82 9.90 
98.33 52.00 18.12 11.11 6.99 
93.33 54.63 17.89 7.80 7.80 
94.44 59.63 17.66 9.64 7.96 
93.89 47.95 23 .59 8.72 10.94 
92.78 50. 17 22.80 8.98 12.36 
95 .00 44.95 20.11 10.10 8.46 
96.67 44.87 16.68 10.63 11.69 
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Table III : Statistical Regression Analysis Data of the Polymer Characteristics on 
the Viscosity of Cellulose Acetate Butyrate Solution. 
Stepwise regression of Viscosity on 4 predictors, with N = 24 
STEP 2 3 
CONSTANT -17.07 19.22 15.29 
Mw 0.00025 0.00021 0.00022 
T-RATIO 9.27 11.05 14.12 
butyryl -0.78 -0.93 
T-RATIO -5.84 -8.03 
hydroxyl 3.39 
T-RATIO 3.52 
s 9.88 6.24 5.03 
R-SQ 79.61 92.23 95.20 
The regression equation is 
Viscosity= 15.3 +0.000222 Mw - 0.930 butyryl + 3.39 hydroxyl 
Predictor Coef Stdev t-ratio p 
Constant 15.292 5.641 2.71 0.013 
Mw 0.00022244 0.00001575 14.12 0.000 
butyryl -0.9297 0.1157 -8.03 0.000 
hydroxyl 3.3876 0.9637 3.52 0.002 
s = 5.028 R-sq = 95.2% R-sq(adj) = 94.5% 
Analysis of Variance 
SOURCE DF 
Regression 3 
Error 20 
Total 23 
SOURCE DF 
Mw 1 
butyryl 
hydroxyl 
SS 
10029.3 
505.7 
10535.0 
SEQ SS 
8386.8 
1330.2 
312.4 
MS 
3343.1 
25.3 
F p 
132.22 0.000 
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Table IV : Statistical Regression Analysis Data of the Polymer Characteristics 
on Polymer Polydispersity. 
Stepwise regression of Polydispersity on 4 predictors, N = 24 
STEP 1 2 
CONSTANT 2.714 2.445 
Mw 0.00001 0.00001 
T-RATIO 8.62 9.46 
hydroxyl 0.085 
T-RATIO 2.30 
s 0.226 0.207 
R-SQ 77.14 81.74 
The regression equation is 
Polydispersity = 2.44 +0.000006 Mw + 0.0851 hydroxyl 
Predictor Coef Stdev t-ratio p , 
/ 
~·/ Constant 2.4445 0.1523 16.06 0.000 
Mw 0.00000595 0.00000063 9.46 0.000 
hydroxyl 0.08511 0.03702 2.30 0.032 
s = 0.2071 R-sq = 81.7% R-sq(adj) = 80.0% 
Analysis of Variance 
SOURCE DF SS MS F p 
Regression 2 4.0326 2.0163 47.00 0.000 
Error 21 0.9009 0.0429 
Total 23 4.9336 
SOURCE DF SEQ SS 
Mw 1 3.8059 
hydroxyl 1 0.2268 
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Table V : Statistical Regression Analysis Data of the Polymer Characteristics 
on Yield 
Stepwise regression of yield on 3 predictors, with N = 24. 
STEP 1 
CONSTANT 99.78 
Mw -0.00002 
T-RATIO -3.79 
s 1.93 
R-SQ 39.56 
The regression equation is 
Yield= 99.8 -0.000020 Mw 
Predictor 
Constant 
Mw 
Coef 
99.7822 
-0.00001991 
Stdev 
0.9032 
0.00000525 
t-ratio 
110.48 
-3.79 
s = 1.930 R-sq = 39.6% R-sq(adj) = 36.8% 
Analysis of Variance 
SOURCE 
Regression 
Error 
Total 
DF SS 
1 53.603 
22 81.909 
23 135.512 
MS 
53.603 
3.723 
F p 
14.40 0.001 
100 
p 
0.000 
0.001 
( 
_ ..,.,.. ,-
Table VI : Statistical Regression Analysis Data of the Polymer Characteristics 
on Mean Particle Size 
Stepwise regression of size on 3 predictors, with N = 24 
STEP 2 3 
CONSTANT 18.32 72.58 137.47 
Mw 0.00014 0.00025 0.00018 
T-RATIO 6.84 7.00 7.77 
Polydispersity -20.0 -39.7 
T-RATIO -3.43 -8.23 
Viscosity 0.67 
T-RATIO 6.05 
s 7.56 6.19 3.77 
R-SQ 68.02 79.50 92.75 
The regression equation is 
Mean particle size= 137 +0.000185 Mw - 39.7 Polydispersity + 0.668 Viscosity 
Predictor 
Constant 
Mw 
Polydispersity 
Viscosity 
Coef 
137.47 
0.00018479 
-39.694 
0.6680 
Stdev 
14.54 
0.00002377 
4.821 
0.1105 
t-ratio 
9.46 
7.77 
-8.23 
6.05 
s = 3.773 R-sq = 92.8% R-sq(adj) = 91.7% 
Analysis of Variance 
SOURCE 
Regression 
Error 
Total 
SOURCE DF 
Mw 1 
Polydispersity 
Viscosity 
DF SS 
3 3643.2 
20 284.8 
23 3928.0 
SEQ SS 
2672.0 
450.6 
520.6 
MS F p 
1214.4 85.29 0.000 
14.2 
101 
p 
0.000 
0.000 
0.000 
0.000 
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Table VII : Statistical Regression Analysis Data of the Polymer Characteristics 
on Particle Size Distribution 
Stepwise regression of size distribution on 3 predictors, with N = 24 
STEP 
CONSTANT 5.022 
Mw 0.00006 
T-RATIO 8.08 
s 2.71 
R-SQ 74.79 
The regression equation is 
Distribution= 5.02 +0.000060 Mw 
Predictor Coef Stdev 
Constant 5.022 1.270 
Mw 0.00005960 0.00000738 
t-ratio 
3.95 
8.08 
s=2.713 R-sq = 74.8% R-sq(adj) = 73.6% 
Analysis of Variance 
SOURCE DF SS MS F 
Regression 1 480.39 480.39 65.28 
Error 22 161.91 7.36 
Total 23 642.30 
102 
p 
0.001 
0.000 
p 
0.000 
Table VIII : Statistical Regression Analysis Data of the Polymer Characteristics 
on Degree of Aggregation 
Stepwise regression of aggregation on 3 predictors, with N = 24 
STEP 
CONSTANT 
Mw 
T-RATIO 
s 
R-SQ 
18.02 
-0.00004 
-5.70 
2.30 
59.64 
The regression equation is 
aggregation= 18.0 -0.000036 Mw 
Predictor Coef Stdev 
Constant 18.024 1.078 
Mw -0.00003570 0.00000626 
t-ratio 
16.72 
-5.70 
s = 2.303 R-sq = 59.6% R-sq(adj) = 57.8% 
Analysis of Variance 
SOURCE DF SS MS F 
Regression 1 172.39 172.39 32.51 
Error 22 116.66 5.30 
Total 23 289.05 
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p 
0.000 
0.000 
p 
0.000 
Table IX : Statistical Regression Analysis Data of the Polymer Characteristics 
on Drug Loading 
Stepwise regression of drug loading on 3 predictors, with N = 
STEP 1 2 
CONSTANT 12.2036 -0.4775 
Viscosity -0.053 -0.135 
T-RATIO -3.32 -3.41 
Polydispersity 4.1 
T-RATIO 2.24 
s 1.62 1.49 
R-SQ 33.41 46.25 
The regression equation is 
drug loading= - 0.48 - 0.135 Viscosity+ 4.09 Polydispersity 
Predictor 
Constant 
Viscosity 
Polydispersity 
Coef 
-0.478 
-0.13477 
4.086 
Stdev 
5.679 
0.03948 
1.824 
t-ratio 
-0.08 
-3.41 
2.24 
p 
0.934 
0.003 
0.036 
s = 1.494 R-sq = 46.2% R-sq(adj) = 41.1 % 
Analysis of Variance 
SOURCE 
Regression 
Error 
Total 
DF SS 
2 40.318 
21 46.858 
23 87.175 
MS 
20.159 
2.231 
F p 
9.03 0.001 
104 
24 
( 
Table X : Statistical Analysis Data of the Polymer Characteristics on the Burst 
Release. 
Stepwise regression of burst release on 3 predictors, with N = 24 
STEP 
CONSTANT 
Viscosity 
T-RATIO 
Polydispersity 
T-RATIO 
s 
R-SQ 
1 
0.4662 
-0.0036 
-3.59 
0.104 
36.96 
2 
-0.5349 
-0.0101 
-4.28 
0.32 
2.95 
0.0896 
55.41 
The regression equation is 
burst= - 0.535 - 0.0101 Viscosity+ 0.323 Polydispersity 
Predictor 
Constant 
Viscosity 
Polydispersity 
Coef 
-0.5349 
-0.010131 
0.3226 
Stdev 
0.3407 
0.002368 
0.1094 
t-ratio 
-1.57 
-4.28 
2.95 
p 
0.131 
0.000 
0.008 
s = 0.08960 R-sq = 55.4% R-sq(adj) = 51.2% 
Analysis of Variance 
SOURCE 
Regression 
Error 
Total 
DF SS 
2 0.20947 
21 0.16860 
23 0.37807 
MS 
0.10474 
0.00803 
F p 
13.05 0.000 
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Table XI : Statistical Analysis Data of the Polymer Characteristics on the Steady 
State Release 
Stepwise regression of steady state release on 3 predictors, with N = 24 
No variables entered or removed 
One-Way ANOVA Analysis 
ANALYSIS OF VARIAN CE 
SOURCE DF MS F p 
FACTOR 5 
ERROR 18 
SS 
0.00726 
0.03514 
0.04240 
0.00145 0.74 0.601 
0.00195 
TOTAL 23 
LEVEL N MEAN STD EV 
381-20 4 0.15245 0.05514 
171-15S 4 0.20257 0.06048 
381-2 4 0.18790 0.02641 
531-1 4 0.16748 0.04074 
381-0.1 4 0.16660 0.03882 
553-0.4 4 0.15795 0.03391 
LSD= to.02s.1s (2MSF/4) 112 = 0.0656 while MSE = 0.00195 
None of the differences between any two of the polymers is larger than LSD. 
Therefore, there is no significant difference on the steady state release between the 
six polymers. 
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Table XII : Statistical Analysis Data of the Polymer Characteristics on the Total 
Release in One Hour 
Stepwise regression of total release in 1 hour on 3 predictors, with N = 24 
STEP 1 2 
CONSTANT 0.6419 -0.1267 
Viscosity -0.00388 -0.00887 
T-RATIO -5.35 -5.40 
Polydispersity 0.248 
T-RATIO 3.26 
s 0.0745 0.0622 
R-SQ 56.53 71.15 
The regression equation is 
1 hour= - 0.127 - 0.00887 Viscosity+ 0.248 Polydispersity 
/ Predictor Coef Stdev t-ratio p 
~-~ Constant -0.1267 0.2363 -0.54 0.598 
Viscosity -0.008865 0.001643 -5.40 0.000 
Polydispersity 0.24763 0.07591 3.26 0.004 
s = 0.06215 R-sq = 71.1 % R-sq(adj) = 68.4% 
Analysis of Variance 
SOURCE DF SS MS F p 
Regression 2 0.20003 0.10002 25.89 0.000 
Error 21 0.08112 0.00386 
Total 23 0.28115 
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Table XIII : Statistical Analysis Data of the Polymer Characteristics on the 
Total Release in Eight Hours 
Stepwise regression of total release in 8 hours on 3 predictors, with N = 24 
STEP 1 
CONSTANT 0.9551 
Viscosity -0.00341 
T-RATIO -7.50 
s 0.0467 
R-SQ 71.89 
The regression equation is 
8 hour= 0.955 - 0.00341 Viscosity 
Predictor Coef Stdev 
Constant 0.95515 0.01365 
Viscosity -0.0034102 0.0004547 
t-ratio 
69.97 
-7.50 
p 
0.000 
0.000 
s = 0.04667 R-sq = 71.9% R-sq(adj) = 70.6% 
Analysis of Variance 
SOURCE 
Regression 
Error 
Total 
DF SS 
1 0.12252 
22 0.04791 
23 0.17043 
MS 
0.12252 
0.00218 
F p 
56.26 0.000 
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SELECTION OF SPAN TYPE AND CONCENTRATION 
Between Span 60 and 80, in order to select the suitable Span type and concentration that 
produced the widest differences between the microcapsules that were prepared with the 
highest molecular weight and the lowest molecular weight polymers, a factorial design 
was used 109-111 • The variables selected were the highest molecular weight (Mw = 
264,362 Daltons) and the lower molecular weight polymer (Mw = 67,840 Daltons), 
Span 60 and Span 80 and the concentration levels of 0.2 and 1 %w/w. The data obtained 
(yield, particle size, size distribution, drug loading and degree of aggregation) were 
analyzed by an ANOV A General Linear Model to examine not only the contribution of 
single factors , but also the effects of interactions between the three preselected 
variables, namely, polymer molecular weight, surfactant type and concentration. 
Tabulation of the data were presented in Table I and Table II. 
Investigation of both tables demonstrated that polymer molecular weight is a significant 
factor in the overall characteristics investigated. Particle size was significantly affected 
by polymer molecular weight, surfactant type and the interaction of the three factors 
(polymer molecular weight, surfactant type and surfactant concentration). Low 
molecular weight polymer produced smaller particles and narrower size distribution. 
Span 60 produced smaller particle size microcapsules than Span 80. However surfactant 
type is not a significant factor in size distribution. The concentration effect was not 
significant. However the interaction of polymer molecular weight, surfactant type and 
110 
surfactant concentration was significant to particle size as well as particle size 
distribution. 
This preliminary study indicated that the study was worth investigating polymer 
molecular weight effect further, since polymer molecular weight affected all the pre-
selected responses. Span 80 was selected as a suitable surfactant because it gave a trend 
of lesser degree of aggregation and produced microcapsules with higher drug loading. 
Therefore 1 % Span 80 was used in the final formula. 
111 
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Table I : Selection of The Surfactant Type and Concentration; The Effects of Polymer Molecular Weight, Span Type 
and Concentration on the Yield2 Phil:'.sical Pro~erties and Drug Loading. 
VARIABLES RESPONSES 
Polymer Surfactant Surfactant Yield Particle Size Degree of Drug 
M w (Daltons) Til:'.~e Concentration(%) (%) Size( um) Distribution Aggregation(%) Loading(%) 
98.89 31.91 13.84 13 .07 11.55 
67,840 Span 80 0.2 96.67 27.68 9.13 11.58 12.57 
100.00 26.53 9.30 13.19 10.30 
100.00 19.24 10.20 12.61 12.99 
67,840 Span 80 1.0 97.22 25.44 10.73 11.76 14.40 
100.00 26.91 8.90 13.39 12.68 
94.95 21 .52 9.73 14.19 8.96 
67,840 Span 60 0.2 96.46 26.11 9.22 13 .00 8.80 
100.00 27.37 9.20 10.03 8.93 
N 95.56 25.38 7.20 13.45 7.77 
67,840 Span 60 1.0 97.41 22.81 10.68 13.51 7.77 
100.00 24.91 10.64 11.67 6.16 
93.33 33.32 19.69 9.16 10.87 
264,362 Span 80 0.2 94.44 40.06 16.01 10.64 9.30 
94.44 40.17 15.59 7.94 8.10 
93.89 43.55 22.51 8.72 10.94 
264,362 Span 80 1.0 92.78 44.95 20.11 8.98 12.36 
95.00 44.87 16.68 10.63 8.46 
91.92 34.53 22.85 11.33 8.78 
264,362 Span 60 0.2 92.93 37.13 19.28 13.26 8.30 
100.00 41.73 19.27 10.8 6.13 
86.67 30.35 19.91 8.45 7.01 
264,362 Span 60 1.0 91.48 31.58 11.82 13.52 7.27 
100.00 34.75 14.10 11.37 5.76 
' \ \. 
Table II : p-Value of the Effect of the Factors Using ANO VA Analysis According to 95% Confidence Level. 
FACTORS 
RESPONSES Molecular Surfactant Surfactant Interaction Interaction Interaction Interaction of 
Weight Type Concentration of of of MW &ST&SC 
(Mw) (ST) (SC) MW&ST MW&SC ST&SC 
Mean 
0.000 0.006 0.373 0.079 0.198 0.120 0.004 
Particle Size -- --
Size 
0.000 0.472 0.431 0.864 0.652 0.101 0.042 
Distribution --
\.;.) 
Degree of 
0.023 0.013 0.410 0.692 0.640 0.328 0.113 
Aggregation -- --
Drug 
0.004 0.000 0.866 0.133 0.956 0.009 0.510 
Loading 
The values reported in each cell are the "p-Value". The ones printed in bold are significant at a= 0.05. 
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